Jan Quaegebeur - Academia.edu (original) (raw)
Uploads
Papers by Jan Quaegebeur
Circulation, Nov 22, 2011
Journal of Heart and Lung Transplantation, 2005
The Journal of Thoracic and Cardiovascular Surgery, May 1, 2012
Journal of Heart and Lung Transplantation, Apr 1, 2016
Journal of Heart and Lung Transplantation, Feb 1, 2001
The Journal of Thoracic and Cardiovascular Surgery, Apr 1, 2013
Journal of the American College of Cardiology, Mar 1, 2004
World Journal for Pediatric and Congenital Heart Surgery, Oct 15, 2018
Journal of Heart and Lung Transplantation, 2004
Circulation, Sep 10, 2013
The Journal of Thoracic and Cardiovascular Surgery, Nov 1, 2006
Circulation, Feb 22, 2011
World Journal for Pediatric and Congenital Heart Surgery, Mar 1, 2018
Annals of Surgery, Feb 1, 2011
Perfusion, Oct 17, 2011
Background: The single dose cardioplegia technique for myocardial protection during congenital he... more Background: The single dose cardioplegia technique for myocardial protection during congenital heart surgery is a viable alternative to multidose protocols. Methods: Thirty-four pediatric patients with aortic cross clamp times greater than 90 minutes were grouped by modified adult (MA) multidose solution or del Nido (dN) single dose solution. Also, data from eight patients where the cross clamp times were greater than two hours on one dose of dN solution were included. Results: In the 90-minute plus arm of the study, there were no significant differences between the groups when comparing the risk adjustment for congenital heart surgery (RACHS) (p=0.6), cardiopulmonary bypass times (CPB) (p=0.5), aortic cross camp times (p=0.5), weights (p=0.7) and number of intraoperative exogenous blood units (p=0.5). There were significant differences between the groups (p<0.05) in the number of cardioplegia doses and with perioperative glucose levels. In the greater than two hours group, the incidence of complete heart block (CHB) was 0.125% and there were no deaths or mechanical circulatory support (MCS) devices used. Conclusion: del Nido cardioplegia solution is a reasonable tool for myocardial protection during congenital heart surgery that significantly decreased the number of cardioplegic interventions and perioperative glucose values in our study groups.
Journal of Heart and Lung Transplantation, 2003
Journal of the American College of Cardiology, Mar 1, 2002
Interactive CardioVascular and Thoracic Surgery, 2014
Circulation, Nov 22, 2011
Journal of Heart and Lung Transplantation, 2005
The Journal of Thoracic and Cardiovascular Surgery, May 1, 2012
Journal of Heart and Lung Transplantation, Apr 1, 2016
Journal of Heart and Lung Transplantation, Feb 1, 2001
The Journal of Thoracic and Cardiovascular Surgery, Apr 1, 2013
Journal of the American College of Cardiology, Mar 1, 2004
World Journal for Pediatric and Congenital Heart Surgery, Oct 15, 2018
Journal of Heart and Lung Transplantation, 2004
Circulation, Sep 10, 2013
The Journal of Thoracic and Cardiovascular Surgery, Nov 1, 2006
Circulation, Feb 22, 2011
World Journal for Pediatric and Congenital Heart Surgery, Mar 1, 2018
Annals of Surgery, Feb 1, 2011
Perfusion, Oct 17, 2011
Background: The single dose cardioplegia technique for myocardial protection during congenital he... more Background: The single dose cardioplegia technique for myocardial protection during congenital heart surgery is a viable alternative to multidose protocols. Methods: Thirty-four pediatric patients with aortic cross clamp times greater than 90 minutes were grouped by modified adult (MA) multidose solution or del Nido (dN) single dose solution. Also, data from eight patients where the cross clamp times were greater than two hours on one dose of dN solution were included. Results: In the 90-minute plus arm of the study, there were no significant differences between the groups when comparing the risk adjustment for congenital heart surgery (RACHS) (p=0.6), cardiopulmonary bypass times (CPB) (p=0.5), aortic cross camp times (p=0.5), weights (p=0.7) and number of intraoperative exogenous blood units (p=0.5). There were significant differences between the groups (p<0.05) in the number of cardioplegia doses and with perioperative glucose levels. In the greater than two hours group, the incidence of complete heart block (CHB) was 0.125% and there were no deaths or mechanical circulatory support (MCS) devices used. Conclusion: del Nido cardioplegia solution is a reasonable tool for myocardial protection during congenital heart surgery that significantly decreased the number of cardioplegic interventions and perioperative glucose values in our study groups.
Journal of Heart and Lung Transplantation, 2003
Journal of the American College of Cardiology, Mar 1, 2002
Interactive CardioVascular and Thoracic Surgery, 2014